Affiliation:
1. Institute of Antibiotics, Huashan Hospital, Fudan University, Shanghai, China
2. Department of Laboratory Medicine, Huadong Hospital, Fudan University, Shanghai, China
3. Key Laboratory of Clinical Pharmacology of Antibiotics, Ministry of Health, Shanghai, China
4. Joint Laboratory of Hospital & Enterprise for Pathogen Diagnosis of Drug-resistant Bacterial Infections and Innovative Drug R & D, Shanghai, China
5. Department of Laboratory Medicine, GuiPing People's Hospital, Guangxi, China
Abstract
ABSTRACT
The increasing use of ceftazidime-avibactam has led to the emergence of a wide range of ceftazidime-avibactam-resistant
bla
KPC-2
variants. Particularly, the conventional carbapenemase phenotypic assay exhibited a high false-negative rate for KPC-2 variants. In this study, three colloidal gold immunoassays, including the Gold Mountainriver CGI test, Dynamiker CGI test and NG-Test CARBA5, and GeneXpert Carba-R, were used to detect the presence of KPC-2 carbapenemase and its various variants in 42
Klebsiella pneumoniae
strains. These strains covered
bla
KPC-2
(13/42) and 16 other
bla
KPC-2
variants including
bla
KPC-12
(1/42),
bla
KPC-23
(1/42),
bla
KPC-25
(1/42),
bla
KPC-33
(6/42),
bla
KPC-35
(1/42),
bla
KPC-44
(1/42),
bla
KPC-71
(1/42),
bla
KPC-76
(8/42),
bla
KPC-78
(1/42),
bla
KPC-79
(1/42),
bla
KPC-100
(1/42),
bla
KPC-127
(1/42),
bla
KPC-128
(1/42),
bla
KPC-144
(1/42),
bla
KPC-157
(2/42), and
bla
KPC-180
(1/42). For KPC-2 strains, all four assays showed 100% negative percentage agreement (NPA) and 100% positive percentage agreement (PPA) with sequencing results. For all 16 KPC-2 variants, GeneXpert Carba-R showed 100% NPA and 100% PPA, and the three colloidal gold immunoassays showed 100% NPA, while the PPAs of the Gold Mountainriver CGI test, Dynamiker CGI test, and NG-Test CARBA5 were 87.5%, 87.5%, and 68.8%, respectively. We also found a correlation between the mutation site in the amino acid of the variants and false-negative results by colloidal gold immunoassays. In conclusion, the GeneXpert Carba-R has been proven to be a reliable method in detecting KPC-2 and its variants, and the colloidal gold immunoassay tests offer a practical and cost-effective approach for their detection. For the sample with a negative result by a colloidal gold immunoassay test but not matching the drug-resistant phenotype, it is recommended to retest using another type of kit or the GeneXpert Carba-R assay, which can significantly improve the accuracy of detection.
Funder
MOST | National Natural Science Foundation of China
Science and technology innovation action plan of Shanghai
CHINET
Publisher
American Society for Microbiology